MedPath

TO SEE THE EFFECT OF LOW DOSE INTRAVENOUS KETAMINE ON PAIN FOLLOWING CAESEREAN SECTION UNDER SPINAL ANAESTHESIA.

Phase 2
Conditions
Health Condition 1: O82- Encounter for cesarean delivery without indication
Registration Number
CTRI/2020/02/023498
Lead Sponsor
Bangalore medical college and research institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Parturients who give written informed consent.

2.ASA physical status classes I and II)

3.Age between 19- 35 years

4.Primigravida or multigravida undergoing lower segment caesarean section for the first time.

5.Parturients with uncomplicated full term singleton pregnancy

Exclusion Criteria

1.Parturients refusing to participate in the study .

2.ASA physical class >II

3.Parturients with height <150 cms

4.Parturients with (1) Hypertensive disorders of pregnancy , essential hypertension (2) Anaemia, (3) previous abdominal surgeries, (4) diabetes mellitus, (5) Cardiac disease (8) Abruptio placenta, placenta previa (9) features of increased intracranial pressure

5.Any contraindication to spinal anaesthesia,

6.Known allergy to ketamine or local anaesthetics .

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to assess the effect of single low dose of ketamine intravenously in cesarean section under spinal anaesthesia after delivery of the baby in reducing the incidence of breakthrough pain postoperativelyTimepoint: Pain assessed every 30 min for 6 hrs post caeserean section.
Secondary Outcome Measures
NameTimeMethod
the possibility of prolongation of duration of spinal anaesthesia .Timepoint: Duration of sensory and motor blockade assessed every 30 min post operatively till 6hrs post caeserean section.
© Copyright 2025. All Rights Reserved by MedPath